Agenus Inc.
Anti-LAG-3 antibodies and methods of use thereof
Last updated:
Abstract:
The instant disclosure provides antibodies that specifically bind to LAG-3 (e.g., human LAG-3) and antagonize LAG-3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
Status:
Grant
Type:
Utility
Filling date:
10 Aug 2020
Issue date:
5 Jan 2021